Shanghai Junshi Biosciences Co., Ltd.

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003FF7
HKD
23.16
-0.7 (-2.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Shanghai Junshi Biosciences Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-983.00
-1,433.00
-2,686.00
-3,030.00
-658.00
-1,875.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4.00
-575.00
-72.00
788.00
-33.00
75.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-518.00
-1,496.00
-2,098.00
-1,997.00
-690.00
-1,613.00
Cash Flow from Investing Activities
-1,758.00
-1,024.00
-1,144.00
-344.00
-1,271.00
-854.00
Cash Flow from Financing Activities
2,417.00
1,107.00
783.00
5,132.00
2,134.00
4,959.00
Net Cash Inflow / Outflow
116.00
-1,400.00
-2,451.00
2,898.00
144.00
2,439.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-23.00
13.00
8.00
107.00
-27.00
-51.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Junshi Biosciences Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-983.849140770664
880.956164991247
-1,863.00
-211.68%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4.25765012230716
625.041185201829
-629.00
-100.68%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-518.558835681885
1751.90868641095
-2,269.00
-129.60%
Cash Flow from Investing Activities
-1758.59169387777
-15.182242666746
-1,743.00
-11483.21%
Cash Flow from Financing Activities
2417.08346410736
-1102.20001714203
3,519.00
319.30%
Net Cash Inflow / Outflow
116.391699857736
602.097008770822
-486.00
-80.67%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-23.5412346899721
-32.429417831348
9.00
27.41%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 65.35% vs 28.69% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-518.56
-1,496.50
65.35%